| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $303.6M | +2.2% | +2.9% |
| Cost of Revenue | $157.5M | +4.9% | +5.4% |
| R&D Expense | $40.3M | -0.3% | -3.3% |
| SG&A Expense | $65.4M | -3.1% | +2.4% |
| Operating Income | $30.5M | +2.0% | -4.3% |
| Pre-tax Income | $26.3M | +32.2% | +10.8% |
| Income Tax | $5.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $158.4M | +8.6% | +33.7% |
| Accounts Receivable | $268.0M | +3.5% | -4.3% |
| Current Assets | $862.9M | +7.3% | +9.6% |
| Total Assets | $1.47B | +3.7% | +6.2% |
| Current Liabilities | $574.9M | +11.4% | +15.1% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $96.7M | — | — |
| Capital Expenditures | $11.2M | — | — |
| Investing Cash Flow | -$10.8M | — | — |
| Financing Cash Flow | -$136.1M | — | — |
| Free Cash Flow | $85.6M | — | — |
| -23.6% |
| +24.9% |
| Net Income | $20.5M | +67.0% | +7.3% |
| EPS (Basic) | $0.74 | +68.2% | +10.4% |
| EPS (Diluted) | $0.73 | +65.9% | +9.0% |
| $538.6M |
| +0.2% |
| -0.2% |
| Total Liabilities | $1.18B | +4.7% | +7.7% |
| Stockholders' Equity | $289.5M | -0.4% | +0.4% |